AbbVie Inc. (NYSE: ABBV) reported fourth quarter 2020 earnings results today.
Worldwide net revenues rose 59.2% year-over-year to $13.8 billion on a reported basis. On an operational basis, sales rose 6.8%.
Net earnings attributable to AbbVie were $36 million, or $0.01 per share, compared to $2.8 billion, or $1.88 per share, last year. The GAAP results included a non-cash charge for Skyrizi contingent consideration revaluation based on higher estimated future sales. Adjusted EPS totaled $2.92.
Both revenue and earnings surpassed market projections.
For the full year of 2021, GAAP EPS is expected to be $6.69-6.89 and adjusted EPS is expected to be $12.32-12.52.
Prior performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
